Lymphoedema is a blockage in the lymphatic system that results in the accumulation of excessive amounts of fluid, causing painful and uncomfortable swelling, usually in the arm or leg.
Secondary lymphoedema may occur following treatment for cancer, if the lymphatic system is damaged.
Approximately 20 per cent of survivors from breast, gynaecological and prostate cancer, or melanoma will experience this condition following treatment.
Join the ACMD Challenge Seminar discussion to hear:
- What is lymphoedema?
- How is it detected and managed?
- Possible opportunities for how technology may improve the quality of life for lymphoedema patients.
Challenge Seminar Speakers
- Associate Professor Liz Dylke – President of the Australasian Lymphology Association
- Dr Debbie Geyer – Vice-President – Lymphoedema Association Australia
- Professor Neil Piller – Director of the Lymphoedema Clinical Research Unit
- Associate Professor Ramin Shayan – Plastic Surgeon, St Vincent’s Hospital (Public and Private)Co-Head, Lymphatic Biology Lab; and Director of O’Brien Institute Department, SVI.
Date: Tuesday 14 March 2023
Time: 2:00pm – 3:00pm
“We seek opportunities to improve the quality of life for lymphoedema patients and the management of this chronic condition – the most significant cancer treatment side effect”
Challenge Seminar Speakers
For this Challenge Seminar and Workshop the ACMD acknowledges the support of Australian Medtech Manufacturing Centre. This Victorian Government partnership brings together health and industry stakeholders from across the ecosystem to co-design solutions to frontline healthcare challenges, and grow clinician-led innovation that stimulates local manufacturing, procurement, and industry innovation.